Market Research Report
Asia Pacific Digital Genome Market Forecast 2021-2028
|Published by||Inkwood Research||Product code||991378|
|Published||Content info||142 Pages
Delivery time: 2-3 business days
|Asia Pacific Digital Genome Market Forecast 2021-2028|
|Published: March 1, 2021||Content info: 142 Pages||
The Asia Pacific digital genome market is registered to grow with a CAGR of 10.37%, across the forecast years of 2021 to 2028. The rising research and development, the increasing genomics programs, the growing funding for genomics, and the surging prevalence of chronic diseases are expected to supplement the region's market growth.
The Asia Pacific digital genome market growth is analyzed through the evaluation of China, South Korea, Vietnam, Australia & New Zealand, India, Indonesia, Japan, Thailand, and the rest of the Asia Pacific. India has undertaken the project for human genome diversity, under the Department of Biotechnology's human genetics program. The project was launched at the Indian Statistical Institute (ISI), the Indian Institute of Chemical Biology (IICB), and the Saha Institute of Nuclear Physics (SINP), in 1999, in Kolkata. Thereafter, India's biotechnology division bolstered and witnessed tremendous developments and changes. In 2020, the Department of Biotechnology (DBT) sanctioned the Genome India Project (GIP), entailing a collaboration of 20 institutes, including the Indian Institute of Science. The GIP will encourage new efficiencies in life sciences, medicine, and agriculture.
On the other hand, the government of Thailand launched the Genomics Thailand Initiative in 2019, in order to sequence the genomes of 50,000 Thais, and build the infrastructure to harness genetic data. The project aims to better understand Southeast Asia's unique genome complexities and advances in terms of drug selection and personalized diagnostics. Moreover, it also includes treatments in the avenues of cancer, non-communicable diseases, rare diseases, and infectious conditions. Thus, these factors are anticipated to propel the market growth, over the forecast period.
Leading companies operating in the region's market are, Qiagen, F. Hoffman-La Roche Ltd, Illumina Inc, Thermo Fisher Scientific Inc, etc.